CVS: Spironolactone - Position Statement on MHRA Drug Safety Update

  • Due for review
    30 March 2018
  • Clinical support group
    • Cardiovascular and Lipids
  • Conditions and indicators

Do you want to add this to your CPD record?

Did you find this page helpful?